X-73213937-A-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_021963.4(NAP1L2):​c.556T>A​(p.Tyr186Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,208,692 control chromosomes in the GnomAD database, including 1 homozygotes. There are 90 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y186C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00015 ( 0 hom., 5 hem., cov: 22)
Exomes 𝑓: 0.00023 ( 1 hom. 85 hem. )

Consequence

NAP1L2
NM_021963.4 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.355
Variant links:
Genes affected
NAP1L2 (HGNC:7638): (nucleosome assembly protein 1 like 2) The protein encoded by this intronless gene is a member of the nucleosome assembly protein (NAP) family. The encoded protein represents a class of tissue-specific factors that interact with chromatin to regulate neuronal cell proliferation. [provided by RefSeq, Jan 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.025869906).
BS2
High Hemizygotes in GnomAd4 at 5 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NAP1L2NM_021963.4 linkc.556T>A p.Tyr186Asn missense_variant Exon 1 of 1 ENST00000373517.4 NP_068798.1 Q9ULW6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NAP1L2ENST00000373517.4 linkc.556T>A p.Tyr186Asn missense_variant Exon 1 of 1 6 NM_021963.4 ENSP00000362616.3 Q9ULW6-1

Frequencies

GnomAD3 genomes
AF:
0.000154
AC:
17
AN:
110636
Hom.:
0
Cov.:
22
AF XY:
0.000152
AC XY:
5
AN XY:
32846
show subpopulations
Gnomad AFR
AF:
0.0000329
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000386
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000227
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000224
AC:
41
AN:
183253
Hom.:
1
AF XY:
0.000236
AC XY:
16
AN XY:
67753
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000474
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000306
Gnomad OTH exome
AF:
0.000663
GnomAD4 exome
AF:
0.000229
AC:
251
AN:
1098056
Hom.:
1
Cov.:
32
AF XY:
0.000234
AC XY:
85
AN XY:
363414
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000398
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000257
Gnomad4 OTH exome
AF:
0.000412
GnomAD4 genome
AF:
0.000154
AC:
17
AN:
110636
Hom.:
0
Cov.:
22
AF XY:
0.000152
AC XY:
5
AN XY:
32846
show subpopulations
Gnomad4 AFR
AF:
0.0000329
Gnomad4 AMR
AF:
0.000386
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000227
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000304
Hom.:
1
Bravo
AF:
0.000317
ExAC
AF:
0.000115
AC:
14
EpiCase
AF:
0.000109
EpiControl
AF:
0.000533

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 20, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.556T>A (p.Y186N) alteration is located in exon 1 (coding exon 1) of the NAP1L2 gene. This alteration results from a T to A substitution at nucleotide position 556, causing the tyrosine (Y) at amino acid position 186 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.97
CADD
Benign
10
DANN
Benign
0.63
DEOGEN2
Benign
0.0094
T
FATHMM_MKL
Benign
0.093
N
LIST_S2
Benign
0.53
T
M_CAP
Benign
0.0010
T
MetaRNN
Benign
0.026
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.035
N
PrimateAI
Benign
0.42
T
PROVEAN
Benign
0.24
N
REVEL
Benign
0.022
Sift
Benign
0.51
T
Sift4G
Benign
0.52
T
Polyphen
0.0
B
Vest4
0.12
MutPred
0.40
Loss of phosphorylation at Y186 (P = 0.0174);
MVP
0.043
MPC
0.33
ClinPred
0.021
T
GERP RS
-2.4
Varity_R
0.047
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200694122; hg19: chrX-72433773; COSMIC: COSV100999234; API